009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,340.00
+0.79%Margins
Gross margin
17.6%
EBITDA margin
-0.9%
EBIT margin
2.0%
Net margin
1.3%
FCF margin
0.3%
3.4%
Return on equity
1.7%
Return on assets
3.6%
Return on invested capital
1.30x
Asset turnover
KRW 17.7B
Cash from operations
KRW 3.4K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026